Celldex Therapeutics Inc (CLDX) — Cash Flow Reinvestment Rate

Latest as of December 2008: 0.02x

Celldex Therapeutics Inc (CLDX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2008, reinvesting $26.75K (capex $26.75K ) from operating cash flow of $1.29 Million. Explore CLDX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

$26.75K
Capex + Investments

Operating Cash Flow

$1.29 Million
USD

Capital Expenditures

$26.75K
USD

Celldex Therapeutics Inc Cash Flow Reinvestment Rate (1986–2008)

Historical reinvestment intensity for Celldex Therapeutics Inc across 3 annual periods. Also explore CLDX asset base for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Celldex Therapeutics Inc (1986–2008)

Year-by-year capital reinvestment analysis for Celldex Therapeutics Inc. For live market cap and broader valuation context, see Celldex Therapeutics Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2008 0.07x $1.30 Million $18.28 Million $1.30 Million ▼ -79.3%
2006 0.35x $9.32 Million $27.00 Million $9.32 Million
1986 0.00x $0.00 $12.30 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow